000			03860nam a22005897a 4500
008			211101s20212021 xxu||||| |||| 00| 0 eng d
022			_a1522-1946
040			_aOvid MEDLINE(R)
099			_a34410035
245			_a30-day readmission following urgent and elective transcatheter aortic valve replacement: A Nationwide Readmission Database analysis.
251			_aCatheterization & Cardiovascular Interventions. 98(7):E1026-E1032, 2021 12 01.
252			_aCatheter Cardiovasc Interv. 98(7):E1026-E1032, 2021 12 01.
252			_zCatheter Cardiovasc Interv. 2021 Aug 19
253			_aCatheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
260			_c2021
260			_fFY2022
265			_saheadofprint
265			_sppublish
266			_d2021-11-01
268			_aCatheterization & Cardiovascular Interventions. 2021 Aug 19
269			_fFY2022
520			_aBACKGROUND: Transcatheter aortic valve replacement (TAVR) is being increasingly used for decompensated severe symptomatic aortic stenosis. Data on urgent and elective TAVR readmission is scarce in the literature. Here, we have performed a retrospective cohort study with the Nationwide Readmission Database of 2016 to identify the rate of 30-day all-cause readmission, common causes of readmission, and distribution of morbidity in index admission and readmission after urgent and elective TAVR.
520			_aCONCLUSION: We found that the all-cause 30-day readmission rate was higher in patients who had undergone urgent TAVR. Further studies are needed to better understand this difference. Copyright (c) 2021 Wiley Periodicals LLC.
520			_aMETHODS: We used International Classification of Diseases, Tenth Revision codes (02R.F38H, 02R.F38Z, 02R.F48Z) for identification of all TAVR procedures done in 2016 in patients >18 years old. We found 8379 patients who underwent urgent TAVR and 32,006 patients who underwent elective TAVR in 2016.
520			_aRESULT: The mean age of patients undergoing urgent TAVR was 79 +/- 9.97 years with 44.6% women. The mean age of patients undergoing elective TAVR was 80.7 +/- 8.25 years with 46.2% women. We found the 30-day all-cause readmission rate of 15.5% and 9.5% in patients undergoing urgent and elective TAVR, respectively (p < 0.001). The cardiac cause was the predominant cause of readmission in both groups (43.77% vs. 42.11%, p = 0.57), followed by pulmonary cause, gastrointestinal (GI) cause, and renal cause. Among cardiac causes, congestive heart failure (CHF) was predominant cause of readmission and was similar in both groups (18.73 in urgent TAVR vs. 15.73 in elective TAVR, p = 0.12).
546			_aEnglish
650			_a*Aortic Valve Stenosis
650			_a*Transcatheter Aortic Valve Replacement
650			_aAdolescent
650			_aAged
650			_aAged, 80 and over
650			_aAortic Valve Stenosis/dg [Diagnostic Imaging]
650			_aAortic Valve Stenosis/ep [Epidemiology]
650			_aAortic Valve Stenosis/su [Surgery]
650			_aAortic Valve/dg [Diagnostic Imaging]
650			_aAortic Valve/su [Surgery]
650			_aFemale
650			_aHumans
650			_aMale
650			_aPatient Readmission
650			_aRetrospective Studies
650			_aRisk Factors
650			_aTime Factors
650			_aTranscatheter Aortic Valve Replacement/ae [Adverse Effects]
650			_aTreatment Outcome
651			_aMedStar Union Memorial Hospital
657			_aJournal Article
700			_aGhosh, Raktim K
790			_aAbbott JD, Amgai B, Aronow WS, Bandyopadhyay D, Chakraborty S, Fonarow GC, Ghosh RK, Hajra A, Kapadia S, Koirala S, Lavie CJ, Patel N
856			_uhttps://dx.doi.org/10.1002/ccd.29918 _zhttps://dx.doi.org/10.1002/ccd.29918
942			_cART _dArticle
999			_c6795 _d6795